guanfacine has been researched along with Diabetic Retinopathy in 1 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coves, MJ | 1 |
| Gomis, R | 1 |
| Casamitjana, R | 1 |
| Lienas, V | 1 |
| Vilaradell, E | 1 |
1 other study available for guanfacine and Diabetic Retinopathy
| Article | Year |
|---|---|
Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diab | 1989 |